Related Experiment Videos
The microbiome as a potential biomarker for oesophageal adenocarcinoma
1Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York 10032, NY, USA.
The Lancet. Gastroenterology & Hepatology
|April 14, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical and Culture-Based Predictors of Gut Microbiome Alpha Diversity at the Time of ICU Admission.
Critical care explorations·2026
A generalizable cross-continent prediction of esophageal squamous cell carcinoma using the oral microbiome.
Communications medicine·2026
Biomarker Use in Barrett's Esophagus Surveillance.
The American journal of gastroenterology·2026
A generalizable cross-continent prediction of esophageal squamous cell carcinoma using the oral microbiome.
bioRxiv : the preprint server for biology·2025
Germline multigene panel testing for colorectal cancer: a systematic review and meta-analysis.
The lancet. Gastroenterology & hepatology·2026
ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial.
The lancet. Gastroenterology & hepatology·2026
The trajectory of inflammatory bowel disease in east and southeast Asia: transitioning from acceleration in incidence to compounding prevalence.
The lancet. Gastroenterology & hepatology·2026
A blood-based test for detection of advanced adenomas and colorectal cancer (DENEB): a multicentre diagnostic accuracy study.
The lancet. Gastroenterology & hepatology·2026
An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.
Neurological research·2026
Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026
Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.
Endocrine-related cancer·2026
Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.
Cancer cytopathology·2026
PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.
Pakistan journal of pharmaceutical sciences·2026